Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Anti-obesity Medicine Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-obesity Medicine Market Perspective (2018-2034)
2.2 Anti-obesity Medicine Growth Trends by Region
2.2.1 Global Anti-obesity Medicine Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Anti-obesity Medicine Historic Market Size by Region (2018-2023)
2.2.3 Anti-obesity Medicine Forecasted Market Size by Region (2024-2034)
2.3 Anti-obesity Medicine Market Dynamics
2.3.1 Anti-obesity Medicine Industry Trends
2.3.2 Anti-obesity Medicine Market Drivers
2.3.3 Anti-obesity Medicine Market Challenges
2.3.4 Anti-obesity Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-obesity Medicine Players by Revenue
3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2018-2023)
3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
3.4 Global Anti-obesity Medicine Market Concentration Ratio
3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2024
3.5 Anti-obesity Medicine Key Players Head office and Area Served
3.6 Key Players Anti-obesity Medicine Product Solution and Service
3.7 Date of Enter into Anti-obesity Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-obesity Medicine Breakdown Data by Type
4.1 Global Anti-obesity Medicine Historic Market Size by Type (2018-2023)
4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2024-2034)
5 Anti-obesity Medicine Breakdown Data by Application
5.1 Global Anti-obesity Medicine Historic Market Size by Application (2018-2023)
5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Anti-obesity Medicine Market Size (2018-2034)
6.2 North America Anti-obesity Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Anti-obesity Medicine Market Size by Country (2018-2023)
6.4 North America Anti-obesity Medicine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-obesity Medicine Market Size (2018-2034)
7.2 Europe Anti-obesity Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Anti-obesity Medicine Market Size by Country (2018-2023)
7.4 Europe Anti-obesity Medicine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-obesity Medicine Market Size (2018-2034)
8.2 Asia-Pacific Anti-obesity Medicine Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Anti-obesity Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-obesity Medicine Market Size (2018-2034)
9.2 Latin America Anti-obesity Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Anti-obesity Medicine Market Size by Country (2018-2023)
9.4 Latin America Anti-obesity Medicine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-obesity Medicine Market Size (2018-2034)
10.2 Middle East & Africa Anti-obesity Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Anti-obesity Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alizyme
11.1.1 Alizyme Company Detail
11.1.2 Alizyme Business Overview
11.1.3 Alizyme Anti-obesity Medicine Introduction
11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2018-2023)
11.1.5 Alizyme Recent Development
11.2 Amylin Pharmaceuticals
11.2.1 Amylin Pharmaceuticals Company Detail
11.2.2 Amylin Pharmaceuticals Business Overview
11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2018-2023)
11.2.5 Amylin Pharmaceuticals Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Detail
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2018-2023)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2018-2023)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Eisai
11.5.1 Eisai Company Detail
11.5.2 Eisai Business Overview
11.5.3 Eisai Anti-obesity Medicine Introduction
11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2018-2023)
11.5.5 Eisai Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Development
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Company Detail
11.7.2 Orexigen Therapeutics Business Overview
11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2018-2023)
11.7.5 Orexigen Therapeutics Recent Development
11.8 Vivus
11.8.1 Vivus Company Detail
11.8.2 Vivus Business Overview
11.8.3 Vivus Anti-obesity Medicine Introduction
11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2018-2023)
11.8.5 Vivus Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-obesity Medicine Introduction
11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Anti-obesity Medicine Introduction
11.10.4 Roche Revenue in Anti-obesity Medicine Business (2018-2023)
11.10.5 Roche Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Anti-obesity Medicine Introduction
11.11.4 Merck Revenue in Anti-obesity Medicine Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Detail
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2018-2023)
11.12.5 Novo Nordisk Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Anti-obesity Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Anti-obesity Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Anti-obesity Medicine Market Share by Region (2018-2023)
Table 8. Global Anti-obesity Medicine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Anti-obesity Medicine Market Share by Region (2024-2034)
Table 10. Anti-obesity Medicine Market Trends
Table 11. Anti-obesity Medicine Market Drivers
Table 12. Anti-obesity Medicine Market Challenges
Table 13. Anti-obesity Medicine Market Restraints
Table 14. Global Anti-obesity Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Anti-obesity Medicine Market Share by Players (2018-2023)
Table 16. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Medicine as of 2024)
Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-obesity Medicine Product Solution and Service
Table 21. Date of Enter into Anti-obesity Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-obesity Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2018-2023)
Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2024-2034)
Table 27. Global Anti-obesity Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Anti-obesity Medicine Revenue Market Share by Application (2018-2023)
Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Anti-obesity Medicine Revenue Market Share by Application (2024-2034)
Table 31. North America Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Anti-obesity Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Anti-obesity Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Anti-obesity Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Anti-obesity Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Anti-obesity Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Anti-obesity Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Anti-obesity Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Anti-obesity Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Anti-obesity Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Anti-obesity Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Anti-obesity Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 46. Alizyme Company Detail
Table 47. Alizyme Business Overview
Table 48. Alizyme Anti-obesity Medicine Product
Table 49. Alizyme Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 50. Alizyme Recent Development
Table 51. Amylin Pharmaceuticals Company Detail
Table 52. Amylin Pharmaceuticals Business Overview
Table 53. Amylin Pharmaceuticals Anti-obesity Medicine Product
Table 54. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 55. Amylin Pharmaceuticals Recent Development
Table 56. Arena Pharmaceuticals Company Detail
Table 57. Arena Pharmaceuticals Business Overview
Table 58. Arena Pharmaceuticals Anti-obesity Medicine Product
Table 59. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 60. Arena Pharmaceuticals Recent Development
Table 61. Boehringer Ingelheim Company Detail
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Anti-obesity Medicine Product
Table 64. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Eisai Company Detail
Table 67. Eisai Business Overview
Table 68. Eisai Anti-obesity Medicine Product
Table 69. Eisai Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 70. Eisai Recent Development
Table 71. GlaxoSmithKline Company Detail
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Anti-obesity Medicine Product
Table 74. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Orexigen Therapeutics Company Detail
Table 77. Orexigen Therapeutics Business Overview
Table 78. Orexigen Therapeutics Anti-obesity Medicine Product
Table 79. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 80. Orexigen Therapeutics Recent Development
Table 81. Vivus Company Detail
Table 82. Vivus Business Overview
Table 83. Vivus Anti-obesity Medicine Product
Table 84. Vivus Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 85. Vivus Recent Development
Table 86. Pfizer Company Detail
Table 87. Pfizer Business Overview
Table 88. Pfizer Anti-obesity Medicine Product
Table 89. Pfizer Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Roche Company Detail
Table 92. Roche Business Overview
Table 93. Roche Anti-obesity Medicine Product
Table 94. Roche Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Anti-obesity Medicine Product
Table 99. Merck Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Novo Nordisk Company Detail
Table 102. Novo Nordisk Business Overview
Table 103. Novo Nordisk Anti-obesity Medicine Product
Table 104. Novo Nordisk Revenue in Anti-obesity Medicine Business (2018-2023) & (US$ Million)
Table 105. Novo Nordisk Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-obesity Medicine Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Anti-obesity Medicine Market Share by Type: 2024 VS 2034
Figure 3. Prescription Drugs Features
Figure 4. OTC Drugs Features
Figure 5. Global Anti-obesity Medicine Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Anti-obesity Medicine Market Share by Application: 2024 VS 2034
Figure 7. Men Case Studies
Figure 8. Women Case Studies
Figure 9. Anti-obesity Medicine Report Years Considered
Figure 10. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 11. Global Anti-obesity Medicine Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Anti-obesity Medicine Market Share by Region: 2024 VS 2034
Figure 13. Global Anti-obesity Medicine Market Share by Players in 2024
Figure 14. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Medicine as of 2024)
Figure 15. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2024
Figure 16. North America Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 17. North America Anti-obesity Medicine Market Share by Country (2018-2034)
Figure 18. United States Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. Canada Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Europe Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Anti-obesity Medicine Market Share by Country (2018-2034)
Figure 22. Germany Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. France Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. U.K. Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Italy Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Russia Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Nordic Countries Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Asia-Pacific Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Anti-obesity Medicine Market Share by Region (2018-2034)
Figure 30. China Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Japan Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. South Korea Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. India Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Australia Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Latin America Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Anti-obesity Medicine Market Share by Country (2018-2034)
Figure 38. Mexico Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Brazil Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Middle East & Africa Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Anti-obesity Medicine Market Share by Country (2018-2034)
Figure 42. Turkey Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 45. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 46. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 48. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 50. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 51. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 55. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed